Coromandel International Limited — Q3 FY24
Coromandel's Q3 FY24 results were sharply down YoY, with consolidated revenue of ₹5,523 crore (-33.8%), EBITDA of ₹358 crore (-54.2%), and PAT of ₹288 crore (-69.3%).
✓ Verified against BSE filing
Did management answer the analysts?
Every material analyst question, graded on whether management actually answered it — with the verbatim exchange and quantitative claims checked against filed numbers.
Impact of new government margin guidelines on Coromandel's profitability.
Asked by Sumant Kumar, Motilal Oswal Financial Services Ltd.
Management clearly explained the new margin guidelines and their categorization.
Read the exchange
So, can you talk about the price fertilizer, non-urea fertilizer and the price control, and government is trying to fix profit margin also...
The government has issued an office memorandum... integrated manufacturers will be able to get a 12% margin... manufacturers who do not have backward integration... could get about a 10%, and importers about 8%.
Inventory loss and phosphoric acid capacity expansion.
Asked by Sumant Kumar, Motilal Oswal Financial Services Ltd.
Management provided specific numbers for capacity addition and inventory loss.
Read the exchange
And the second question is phosphoric acid. Can you guide us how much capacity we are going to increase and any inventory loss in this...?
On the PA capacity, we are looking at, adding about 650 tons per day capacity... inventory, hit is concerned for the quarter... in the range of about INR 30 crore or so.
Clarification on Coromandel's classification under new guidelines.
Asked by Arjun Khanna, Kotak Mahindra Asset Management Company
Management confirmed the classification directly.
Read the exchange
Just to clarify, with the latest guidelines, Coromandel will be treated as an integrated manufacturer? Would that be the right understanding?
Yeah, because we have both granulation as well as phosphoric, sulfuric plants here, we would be an integrated manufacturer.
Impact of unreasonable profit clause on previous year.
Asked by Arjun Khanna, Kotak Mahindra Asset Management Company
Management gave an initial assessment but deferred final conclusion.
Read the exchange
Can you confirm on the call that we would have no impact from that aspect?
This guideline is effective first of April 2023... my initial assessment is it's not likely to have an impact for the company.
Treatment of retail subsidiary margins under new guidelines.
Asked by Arjun Khanna, Kotak Mahindra Asset Management Company
Management clarified that retail margins are included in overall margin.
Read the exchange
Gromor, given it's a subsidiary, would it be subsumed in that 12%, that's considered separately as a dealer, so that impact would be plus?
It will be taken as the same, and the margin that we make on the sales will be considered as the overall margin for the company.
Impact of cash-rich balance sheet on margin calculation.
Asked by Vishnu Kumar, Avendus Spark
Management acknowledged the point but minimized its practical impact.
Read the exchange
Having large cash on balance sheet, would be a detriment to a nutrient or a fertilizer player. Would that be a right understanding?
One can interpret it that way... I don't think it's going to impact to a very great extent, considering the current situation.
Whether 12% PBT margin is on actual or normalized costs.
Asked by Dheeresh Pathak, WhiteOak Capital
Management gave a clear one-word answer.
Read the exchange
Is it going to be on actual basis, or is it going to be on a normalized basis?
It will be on actual.
Why current margins are below 12% PBT despite flexibility.
Asked by Dheeresh Pathak, WhiteOak Capital
Management explained multiple factors including subsidy rates and demand.
Read the exchange
The only reason we are not able to increase MRP is because it is an election year period. Is that the only difference?
Not every year is going to be the same... Last quarter has been tough. The NBS rates have been sharply corrected... there is no point in increasing the MRP and not being able to sell.
Phosphoric acid capacity and backward integration details.
Asked by Bharat Sheth, Quest Investment Advisors Pvt Ltd
Management provided specific capacity numbers and remaining import needs.
Read the exchange
How much capacity have we planned for this phosphoric plant... how much still we need to have a backward integration scope is there?
The phosphoric plant that we are looking at is a 200,000-ton capacity per annum... after this plant comes in place, we will still have about 200,000 tons or so, which we might have to import.
Historical average margins vs new guideline ceilings.
Asked by Gagan Thareja, ASK Investment Managers
Management avoided giving specific historical margin numbers.
Read the exchange
What in your experience have been the cyclical average margins that Coromandel would have seen...?
I may not be able to answer you at the industry level, but if you look at the performance of the company over a period in time, I don't think that companies have hit this line of cap at all.
Progress on crop protection business and Dhaksha drones.
Asked by Ankur Periwal, Axis Capital Ltd.
Management provided volume growth and specific order book number.
Read the exchange
Your thoughts on both B2B as well as B2C growth, and as well as how is the progress going on Dhaksha side?
In Q3, we grew handsomely, in volume terms... we have close to INR 300 crore of an order book for Dhaksha at this point in time.
Reason for stark reduction in per ton margins in Q3.
Asked by Tarun, Old Bridge Asset Management
Management explained the factors clearly.
Read the exchange
What drove such a stark reduction in the per ton margins?
The impact of channel inventory has been taken in Q2 numbers, but the sales in Q3, the subsidy realization is also very low... raw material prices slightly going up.